Month: April 2022

The unmet needs in the treating HCC are present at various stages (early, intermediate, and advanced stages) and in various settings, such as neoadjuvant and/or adjuvant settings before and after resection [31,32] or ablation [33,34], adjuvant settings after transcatheter arterial chemoembolization [35,36], and first- or second-line treatment for advanced HCC

The unmet needs in the treating HCC are present at various stages (early, intermediate, and advanced stages) and in various settings, such as neoadjuvant and/or […]

Continue reading